About Atlas Antibodies
Atlas Antibodies is a company based in Stockholm (Sweden) founded in 2006.. Atlas Antibodies has completed 2 acquisitions, including HistoCyte Laboratories and evitria. Atlas Antibodies operates in a competitive market with competitors including Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others.
- Headquarter Stockholm, Sweden
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
HistoCyte Laboratories
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Atlas Antibodies
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2006 | Amount | Seed - Atlas Antibodies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Atlas Antibodies
Atlas Antibodies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Investor Growth Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Atlas Antibodies
Atlas Antibodies has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include HistoCyte Laboratories and evitria. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of same-slide control reagents for histopathololgy
|
2014 | ||||
|
Transient protein expression services in CHO cells are provided.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Atlas Antibodies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atlas Antibodies Comparisons
Competitors of Atlas Antibodies
Atlas Antibodies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sino Biological, GenScript, Mabtech, Y-Biologics and Epitomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Reagents and kits are provided for clinical research applications.
|
|
| domain | founded_year | HQ Location |
Reagents and instruments are provided for life sciences research.
|
|
| domain | founded_year | HQ Location |
Antibodies and immunoassay kits are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies for the treatment of multiple diseases
|
|
| domain | founded_year | HQ Location |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| domain | founded_year | HQ Location |
Technology for antibody-drug conjugation is provided by AbTis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Atlas Antibodies
Frequently Asked Questions about Atlas Antibodies
When was Atlas Antibodies founded?
Atlas Antibodies was founded in 2006.
Where is Atlas Antibodies located?
Atlas Antibodies is headquartered in Stockholm, Sweden.
What does Atlas Antibodies do?
Atlas Antibodies was founded in 2006 in Stockholm, Sweden, emerging from the Human Protein Atlas project focused on antibody development for human proteins. Primary antibodies, blocking antigens, antibody panels, and mass spectrometry standards are offered, covering 17,000 antibodies for 15,000 gene products and 19,000 MS standards for 13,000 protein targets. Operations center on biotechnology, with ongoing development of reagents for quantitative proteomics and proprietary diagnostic or therapeutic applications.
Who are the top competitors of Atlas Antibodies?
Atlas Antibodies's top competitors include Sino Biological, GenScript and Y-Biologics.
How many acquisitions has Atlas Antibodies made?
Atlas Antibodies has made 2 acquisitions, including HistoCyte Laboratories, and evitria.
Who are Atlas Antibodies's investors?
Atlas Antibodies has 1 investor. Key investors include Investor Growth Capital.